期刊文献+

均值漂移算法的铁路护栏网格提取 被引量:4

Analysis of the Medication on Anticancer Drugs in Shanghai Sample Hospitals from 2011 to 2013
下载PDF
导出
摘要 针对铁路沿线护栏的检测问题,提出了一种改进的均值漂移算法。首先,从阈值分割算法入手,得到铁路防护栏网格区域的颜色范围;然后,基于均值漂移算法对其进行图像平滑和分割;再针对产生的过分割图像,采用基于最小面积的合并停止准则来进行区域合并;最后进行网格提取。实例验证表明:改进的均值漂移算法的效果优于传统的均值漂移算法。 Objective: To investigate the clinical application of anticancer drugs in Shanghai sample hospitals during 2011-2013 so as to provide references for the production, marketing and application and etc. Methods: The data on anticancer drugs used in 119 Shanghai sample hospitals were compared and analyzed in respect to the clinical applications. Results: The demand for anticancer drugs had been rapidly growing. The main varieties are gimeracil and oteracil porassium capsules, pemetrexed, trastuzumab, "Xiaoaiping" and "Kangai" and etc. Conclusion: Prospect for the development of anticancer drugs is a very large market. It is urgent to develop effective, safe and inexpensive anticancer drugs.
作者 归成 刘皋林 GUI Cheng, LIU Gao-lin( Department of Clinical Pharmacy, Affiliated First People's Hospital of Shanghai Jiao Tong University, Shanghai 200080, China)
出处 《药品评价》 CAS 2015年第2期28-32,共5页 Drug Evaluation
基金 国家自然科学基金项目(5136501) 江西省自然科学基金项目(20132BAB203020) 江西省教育厅科学技术研究项目(GJJ13430)
关键词 铁路护栏 网格提取 阈值分割 均值漂移 区域合并 Anticancer Drugs Shanghai Sample Hospitals Amount of Money Medication Tendency
  • 相关文献

参考文献5

二级参考文献39

  • 1Chattopadhyay S,Moran RG,Goldman ID,et al.Pemetrexed:biochemical and cellular pharmacology,mechanisms,and clinical applications[J].Mol Cancer Ther,2007,6(2):404-417.
  • 2Britten CD,Izbicka E,Hilsenbeck S,et al.Activity of the multitargeted antifolate LY231514 in the tumor coloning assay[J].Cancer Chemother Pharmaco,1999,44(2):105-110.
  • 3Nicholas J,Vogelzang NJ,James J,et al.Phase Ⅲ study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleuralmesothelioma[J].Clin Oncol,2003,21(14):2636-2644.
  • 4Monnerat C,le Chevalier T.Review of the pemetrexed and gemcitabine combination in patients with advanced-stage non-small cell lung cancer[J].Ann Oncol,2006,17(suppl 5):v85-v90.
  • 5de Marinis F,de Santis S,de Detris L.Second-line chemotherapy for non-small cell lung cancer[J].Ann Oncol,2006,17(suppl 5):v68-v71.
  • 6Hsu SC, Hung MC. Characterization of a novel tripartite nuclear localization sequence in the EGFR family [J]. J Biol Chem, 2007, 282(14): 10432-10440.
  • 7Milanezi F, Carvalho S, Schnfitt FC. EGFR/HER2 in breast cancer: a biological approach for molecular diagnosis and therapy [J]. Expe Rev Mol Diagu, 2008, 8(4): 417.
  • 8Niemiec JA, Adamczyk A, Maecki K, et al. Relationships between immunophenotype, Ki-67 index, microvascular density, Ep-CAM/ P-cadherin, and MMP-2 expression in early-stage invasive duetal breast cancer [J]. Appl [Epub ahead of print] Mol Morpho12012 Apr 23.
  • 9Erdem O, Dursun A, Cosktm U, et al. the prognostic value of p53 and cerbB-2 expression, proliferative activity and angiogenesis in nodeegative breast cancer [J]. Tumor, 2005, 91(1): 46-52.
  • 10Rivas MA, Tkach M, Beguelin W, et al. Transactivation of ErbB- 2 induced by tumor necrosis factor alpha promotes NF-kappaB activation and breast cancer cell proliferation [J]. Breast Cancer Res Treat, 2010, 122(1): 111-124.

共引文献542

同被引文献33

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部